INTRODUCTION
The increasing emergence of antimicrobial resistance in both the community and inpatient settings has become an alarming public health concern. Infections caused by resistant organisms have been shown to increase morbidity, mortality, and healthcare costs [1] . The emergence of antimicrobial resistance has been linked to the overuse and inappropriate prescribing of antimicrobial therapy [2, 3] . Because it serves as a link in transitions of care, the emergency department (ED) represents an important target for interventions aimed at decreasing inappropriate antimicrobial use, especially in the outpatient setting. ED's across the United States are estimated to treat over 100 million patients annually, with approximately 15.7% of patients discharged home with a prescription for an antimicrobial agent [4] [5] [6] [7] . In the ED setting, many patients are discharged home prior to culture and susceptibility results becoming final. It has been reported that 5.6% of patients discharged from the ED receive an inappropriate medication at discharge [4] .
While institution-specific empiric therapy guidelines can help to align therapy with national guidelines and institutional-specific antibiogram data, pathogens are not always susceptible to empiric therapy choices.
Prescribing of inappropriate antimicrobials puts patients at risk for clinical failure and subsequent revisit to the ED and readmission to the hospital [8, 9] . Therefore, further process improvements such as structured culture follow-up programs must be considered to improve antimicrobial use in the ED setting.
Cosgrove and colleagues recently published a call to action for antimicrobial stewardship in the ED, highlighting the importance of judicious antimicrobial use and also the important opportunity for antimicrobial stewardship collaboration [10] . ED clinicians play a prominent role in antimicrobial stewardship; not only are they tasked with choosing an appropriate antimicrobial regimen but also sending indicated cultures and performing follow-up. Pharmacists also play a prominent role in antimicrobial stewardship programs (ASPs) within hospitals and health systems due to their knowledge of antimicrobial activity, dosing, and drug interactions [11] [12] [13] .
Several institutions have described their experience with antimicrobial stewardship in the emergency department [14] [15] [16] [17] ; however, the optimal targets for intervention in this setting have not been established. 
METHODS

Study Design and Setting
This study was conducted at an 802-bed teaching hospital in Detroit, Michigan, with an existing ASP presence in inpatient and ED services. The authors conducted a single pre-test, post-test quasi-experimental study comparing the standard of care (SOC) to a multidisciplinary (CFU) program. The CFU program was implemented primarily by a pharmacy practice resident (PGY1), with support and oversight from the infectious diseases and ED pharmacy specialists.
Compliance with Ethics
The study was approved by the Henry Ford Health System Institutional Review Board and all procedures followed were in accordance with the ethical standards of the responsible 
Selection of Participants
Patients were included who were 18 years of age or older, presented to the main campus ED, were discharged to home from the ED, and had a blood or urine culture taken which yielded a positive result. For patients with multiple ED visits meeting these criteria, the first visit was included in the study population. 
Intervention
Prior to the CFU program, the SOC for CFU consisted of prescriber-dependent follow-up.
Each prescriber was responsible for performing culture follow-up for any patient whom they saw and discharged directly home from the ED. 
Data Collection
For all patients in the study population, data were extracted from electronic medical records by trained investigators using a standardized case report form. Data collected included patient demographics, infection and microbiological characteristics, empiric antimicrobial therapy, ED revisit within 72 h, and hospital admission within 30 days. Time to appropriate therapy was recorded in days and calculated as the day from initial ED discharge to the day that the ED physician made their first follow-up contact attempt with the patient. The primary endpoint for analysis was a composite of patient revisit to the ED within 72 h of index ED discharge or admission to the hospital within 30 days of index ED discharge. A revisit to the ED was defined as any unplanned presentation for the same condition within 72 h of initial discharge [18, 19] .
Analysis
The study was powered to detect a 12% reduction in ED revisit or hospital admission per patient compared to the previous standard of care using a two-sided test with a significance of 0.05 and 80% power [15] . The authors calculated that 139 patients per phase would need to be included in this study (n = 276 patients total). Based on the findings of Rynn and colleagues [16] the authors anticipated that 25% of patients would require therapeutic modification.
For all study endpoints as well as patient and infection characteristics, categorical data were compared using Chi square or Fisher's exact test; continuous data were compared using Student's t or Mann-Whitney U tests, as appropriate for the distribution of the data.
Characteristics found to be associated with the outcome in bivariate tests with a p\0.2 and clinical rationale were considered for inclusion in a multivariable logistic regression model. The primary population for analysis was the total number of cultures; subgroup analyses were conducted for each culture site as specified a priori. Post-hoc subgroup analysis according to insurance status was also performed. A p\0.05 was considered significant for all comparisons.
Statistical analysis was completed using SPSS 19.0 (IBM, Inc., Armonk, NY, USA).
RESULTS
Characteristics of Study Subjects
A total of 320 patients with 321 cultures were included in the final analysis. Over the fourmonth intervention period 651 cultures were screened and 197 met inclusion criteria for the CFU group. In the four-month retrospective SOC group, 324 cultures were screened and 124
were included for comparison. Cultures were excluded from analysis based on patient age or hospice status, because the patient was admitted to the hospital for treatment, or because the culture was taken at a satellite ED.
The overwhelming majority of patients in both groups had positive urine cultures (307 out of 321). Patient characteristics are displayed in 
Infection and Treatment Characteristics
Of the 307 urine cultures included, 100% of patients in both the SOC and the CFU group had a urinalysis sample taken at baseline.
In the SOC group 73.3% of patients had documentation of symptomatic urinary tract infection while 74.9% of the CFU group were symptomatic (p = 0.764). Escherichia coli was the most commonly identified urinary pathogen in both groups. In the SOC group, sulfamethoxazole-trimethoprim (TMP-SMX) was the most often prescribed agent for empiric treatment, followed by ciprofloxacin and cephalexin. In the CFU group, ciprofloxacin was the most commonly prescribed agent for empiric treatment, followed by nitrofurantoin and TMP-SMX. The average length of empiric therapy was 8.45 days in the SOC group and 7.59 days in the CFU group. Table 2 ) Of the 21 patients having either an ED revisit or hospital admission in the SOC group, 76.2% returned due to an infection-related issue, while 55% of the 20 patients admitted in the CFU group returned for an infectionrelated issue (p = 0.153). In the subset of patients without medical insurance, 59 in the SOC group and 41 in the CFU group, the 72-h revisits to the ED were significantly reduced from 15.3% in the SOC group to 2.4% in the CFU group (p = 0.044). There was no difference in the incidence of hospital admissions at 30 days in this subset.
The Interestingly, the subgroup analysis in the uninsured population suggests that this intervention could have a dramatic impact in populations with limited access to care.
Other characteristics found to be associated with improved outcome were documented urinary frequency and dysuria; the authors speculate that this may be related to improved awareness and aggressive antimicrobial therapy among ED providers responding to these welldefined symptoms of urinary tract infections. In addition, the authors noted a numerical increase in appropriate empiric therapy and a significant increase in the use of nitrofurantoin in the CFU group, corresponding to a change in national and institutional recommendations for cystitis [20] . Despite this, intervention by the multidisciplinary CFU providers was still necessary in 25.5% of cases, and the most common reason for intervention was pathogen non-susceptibility. This is similar to reports from antimicrobial stewardship programs in other EDs with intervention rates ranging from 15 to 25% [15, 16] . This variance may be due in part to the population that each institution chooses to target. Whilst the authors limited their intervention to urine and blood cultures, others have also included sexually transmitted diseases, skin and skin structure infection, and respiratory tract infections.
There are potential limitations to this study that must be considered. [21] . A quasi-experimental design was selected for the study because withholding multidisciplinary follow-up from randomly selected patients would be impractical and potentially unethical. Last, while the authors believe the decrease in ED revisits and hospital admissions was significant to their institution, this study did not achieve the effect size for which it was designed, possibly due to the numerical increase in appropriate empiric therapy also seen after implementation of the CFU group when compared to the SOC. The impact of this study may have been greater with the inclusion of follow-up for sexually transmitted diseases (STDs) and other sites of bacterial culture.
CONCLUSION
Over a 4-month period, a multidisciplinary culture follow-up program in the ED was effective in improving the quality of care, but did not achieve a statistical reduction in ED revisit and hospital admission compared to standard of care. Interventions targeting infection management in high-risk ED patients may show an even greater impact.
Antimicrobial stewardship interventions at the transition of care were required in one-fourth of patients, supporting the need for continued expansion of antimicrobial stewardship services in the ED.
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